Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $16.7 million.

  • SOPHiA GENETICS's Accumulated Expenses rose 2098.71% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 2098.71%. This contributed to the annual value of $13.2 million for FY2024, which is 2578.05% down from last year.
  • As of Q3 2025, SOPHiA GENETICS's Accumulated Expenses stood at $16.7 million, which was up 2098.71% from $13.7 million recorded in Q2 2025.
  • SOPHiA GENETICS's Accumulated Expenses' 5-year high stood at $17.8 million during Q4 2023, with a 5-year trough of $10.5 million in Q1 2023.
  • Over the past 5 years, SOPHiA GENETICS's median Accumulated Expenses value was $13.8 million (recorded in 2023), while the average stood at $13.9 million.
  • In the last 5 years, SOPHiA GENETICS's Accumulated Expenses skyrocketed by 7588.37% in 2021 and then tumbled by 3162.82% in 2023.
  • Over the past 5 years, SOPHiA GENETICS's Accumulated Expenses (Quarter) stood at $16.0 million in 2021, then decreased by 9.18% to $14.5 million in 2022, then rose by 22.77% to $17.8 million in 2023, then decreased by 25.78% to $13.2 million in 2024, then increased by 26.49% to $16.7 million in 2025.
  • Its Accumulated Expenses was $16.7 million in Q3 2025, compared to $13.7 million in Q2 2025 and $11.7 million in Q1 2025.